当前位置:首页 - 行情中心 - 三元生物(301206) - 财务分析 - 现金流量表

三元生物

(301206)

  

流通市值:38.12亿  总市值:59.20亿
流通股本:1.30亿   总股本:2.02亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金369,921,011.53172,819,121.39691,411,243.9532,393,814.21
  收到的税费返还26,525,937.7217,852,236.5559,747,217.2847,440,772.44
  收到其他与经营活动有关的现金4,852,660.123,434,909.984,340,986.255,833,281.94
  经营活动现金流入小计401,299,609.37194,106,267.92755,499,447.43585,667,868.59
  购买商品、接受劳务支付的现金338,994,006.24125,529,484.03698,733,103.02521,886,099.16
  支付给职工以及为职工支付的现金29,056,758.2315,900,322.5454,866,993.3640,753,438.69
  支付的各项税费22,289,607.376,518,314.293,066,162.086,459,482.82
  支付其他与经营活动有关的现金9,036,784.885,389,780.5812,482,699.369,597,934.15
  经营活动现金流出小计399,377,156.72153,337,901.44769,148,957.82578,696,954.82
  经营活动产生的现金流量净额1,922,452.6540,768,366.48-13,649,510.396,970,913.77
二、投资活动产生的现金流量:
  收回投资收到的现金7,890,100,0005,604,000,000873,300,000360,000,000
  取得投资收益收到的现金292,042,664.91268,602,026.4834,781,299.8234,266,579.27
  处置固定资产、无形资产和其他长期资产收回的现金净额3,6352,500--
  收到的其他与投资活动有关的现金5,460,0001,310,000500,000500,000
  投资活动现金流入小计8,187,606,299.915,873,914,526.48908,581,299.82394,766,579.27
  购建固定资产、无形资产和其他长期资产支付的现金109,780,064.2441,731,088.09141,764,714.19115,593,369.58
  投资支付的现金7,706,800,0004,325,800,000600,653,917.81220,653,917.81
  支付其他与投资活动有关的现金5,160,000-500,000500,000
  投资活动现金流出小计7,821,740,064.244,367,531,088.09742,918,632336,747,287.39
  投资活动产生的现金流量净额365,866,235.671,506,383,438.39165,662,667.8258,019,291.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金400,000400,000--
  收到其他与筹资活动有关的现金2,000,000-2,000,000-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计2,400,000400,0002,000,000-
  分配股利、利润或偿付利息支付的现金239,296,365.3149,100,015.6980,895,868.7279,174,488.16
  支付其他与筹资活动有关的现金45,091,550.5623,877,229.1619,604,440.211,113,724.66
  筹资活动现金流出小计284,387,915.8772,977,244.85100,500,308.9290,288,212.82
  筹资活动产生的现金流量净额-281,987,915.87-72,577,244.85-98,500,308.92-90,288,212.82
四、汇率变动对现金及现金等价物的影响164,489.37-485,719.122,812,134.492,154,656.24
五、现金及现金等价物净增加额85,965,261.821,474,088,840.956,324,983-23,143,350.93
  加:期初现金及现金等价物余额160,292,353.03160,292,353.03103,967,370.03103,967,370.03
  期末现金及现金等价物余额246,257,614.851,634,381,193.93160,292,353.0380,824,019.1
补充资料:
  净利润57,367,849.85-104,951,340.17-
  固定资产和投资性房地产折旧35,910,478.45-65,112,495.39-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧35,910,478.45-65,112,495.39-
  无形资产摊销545,791.26-1,150,813.01-
  处置固定资产、无形资产和其他长期资产的损失36,368.8---
  固定资产报废损失--68,204.12-
  投资损失-36,233,619.1--108,578,694.29-
  递延所得税-11,229,942.75-23,253,017.46-
    递延所得税负债增加-11,229,942.75-23,253,017.46-
  存货的减少-48,655,213.17--38,376,082.53-
  经营性应收项目的减少52,316,936.62--42,171,459.22-
  经营性应付项目的增加-48,300,570.23--19,701,184.77-
  现金的期末余额246,257,614.85-160,292,353.03-
  减:现金的期初余额160,292,353.03-103,967,370.03-
  现金及现金等价物的净增加额85,965,261.82-56,324,983-
公告日期2025-08-292025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑